Research map: Reimagining Hepatitis C Elimination: Time for Actions, Not Targets

Back to the article

Papers in this map

  1. A same day ‘test and treat’ model for chronic HCV and HBV infection: Results from two community‐based pilot studies in Egypt · Gamal El-Sayed Shiha · 2020 · 47 citations · Cited by this paper
  2. Mpox Vaccination and Diagnosis Among Sexual and Gender Diverse Populations in Brazil: Results From a Large Nationwide Online Survey · Mayara Secco Torres Silva · 2026 · 1 citation · Related
  3. New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances · Stefania Chiappini · 2024 · 40 citations · Cited by this paper
  4. Using Tenofovir Diphosphate Levels to Evaluate Factors Associated With PrEP Non‐Adherence and Performance of Indirect Adherence Measures in Latin America: A Prospective, Single‐Arm, Open‐Label, Multicentre Implementation Study (ImPrEP) · Thiago S. Torres · 2026 · 1 citation · Related
  5. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019 · Daniela K van Santen · 2022 · 39 citations · Cited by this paper
  6. Integrating HIV Into Sexual and Reproductive Health Services for Female Sex Workers in Buenos Aires, Argentina: A Comprehensive Model Designed Through Intersectional Collaboration · María Macarena Sandoval · 2026 · 1 citation · Related
  7. Eliminating hepatitis C: The importance of frequent testing of people who inject drugs in high‐prevalence settings · Nick Scott · 2018 · 38 citations · Cited by this paper
  8. Durability of the Humoral Response to MPXV Infection · Tara N. Palmore · 2026 · 1 citation · Related
  9. The Payer License Agreement, or “Netflix model,” for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition · David W. Matthews · 2022 · 19 citations · Cited by this paper
  10. Towards Elimination of Sexually Transmitted Infections: Research Developments and Vaccine Uptake · Jeanne Marrazzo · 2026 · Related
  11. Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility · Michael B. MacIsaac · 2024 · 16 citations · Cited by this paper
  12. Latin America and the Caribbean: Socioeconomic Realities and Implications for Health and HIV Responses · Claudia P. Cortés · 2026 · Related
  13. HCV reinfection as a positive indication of high‐risk population treatment access · Gregory J. Dore · 2019 · 10 citations · Cited by this paper
  14. Facilitators and Barriers to Implementing Peer‐Led Neurocognitive Screening for Older Adults Living With HIV at a Community Hospital in Thailand: A Multiple‐Methods Study · 2026 · Related
  15. A Multicenter, open-label, randomized, non-inferiority trial of 8 versus 12 weeks of sofosbuvir/ravidasvir treatment in non-cirrhotic patients with chronic hepatitis C virus infection (EASE trial) · Muhammad Radzi Abu Hassan · 2026 · 3 citations · Cited by this paper
  16. Progress and Challenges in Elimination of Vertical HIV Transmission · 2026 · Related
  17. Cost-effectiveness of Alternative Approaches to Hepatitis C Diagnosis and Treatment Initiation for Treatment-naive People Who Inject Drugs in Australia: A Model-based Economic Evaluation · Christopher R. Bailie · 2025 · 2 citations · Cited by this paper
  18. Correlates of Poor Quality of Life Among Older People Living With HIV: A Cross‐Sectional Analysis of the Tanzania HIV and Aging Cohort Study · 2026 · Related
  19. Cost-Effectiveness of Point-of-Care Hepatitis C Virus RNA Testing in the US · Neda Al Rawashdh · 2026 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)